¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"HIV encephalitis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® encephalitis ÇÑ±Û ³ú¿°
¼³¸í   
  ³úÀÇ ¿°Áõ¼º Áúȯ. ³ú½ÇÁú »Ó ¾Æ´Ï¶ó ³ú¸·-ô¼ö, ¶§·Î´Â ¸»ÃʽŰ濡µµ ÀϾ ¼ö ÀÖ´Ù. ¹ÙÀÌ·¯½º¼º ³ú¿°°ú ÃâÇ÷¼º ³ú¿°À¸·Î Å©°Ô ³ª´«´Ù. ÀüÀڴ ¹ÙÀÌ·¯½º °¨¿°¿¡ ÀÇÇÑ Áø¼º³ú¿°À¸·Î ´ëºÎºÐÀÇ ³ú¿°ÀÌ ÀÌ¿¡ Æ÷ÇԵǰí Á¾·ùµµ ¸¹´Ù. ¨ç ¹ÙÀÌ·¯½º °¨¿°¿¡ ÀÇÇØ À¯Ç༺À¸·Î ¹ß»ýÇϴ °ÍÀ¸·Î ÀϺ»³ú¿°-Á¹À½³ú¿° µîÀÌ ÀÌ¿¡ Æ÷ÇԵȴÙ. ¨è È«¿ªÀ̳ª À¯Ç༺ º¼°Å¸®¿°¿¡ °É·ÈÀ» ¶§ º´¿ø¹ÙÀÌ·¯½º°¡ È¯ÀÚÀÇ ³ú¸¦ Ä§¹üÇÑ °Í µîÀÌ ÀÌ¿¡ Æ÷ÇԵȴÙ. ¨é Á¾µÎÁ¢Á¾ ÈÄ ³ú¿°Ã³·³ °¨¿°ÈÄ¿¡ ¹ß»ýµÇ´Â ³ú¿° µîÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • HIV
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • arthropod-borne encephalitis
    ÀýÁöµ¿¹°¸Å°³³ú¿°
  • acute disseminated encephalitis
    ±Þ¼ºÆÄÁ¾³ú¿°
  • bunyavirus encephalitis
    ¹ö³Ä¹ÙÀÌ·¯½º³ú¿°
  • Coxsackie encephalitis
    ÄÛ»çŰ¹ÙÀÌ·¯½º³ú¿°
  • encephalitis
    ³ú¿°
  • epidemic encephalitis
    À¯Çà(¼º)³ú¿°
  • equine encephalitis
    ¸»³ú¿°
  • forest spring encephalitis
    »ï¸²º½Ã¶³ú¿°
  • hemorrhagic encephalitis
    ÃâÇ÷³ú¿°
  • herpes simplex encephalitis
    ´Ü¼øÇ츣Æä½º³ú¿°
  • Japanese B encephalitis virus
    ÀϺ»BÇü³ú¿°¹ÙÀÌ·¯½º
  • Japanese encephalitis
    ÀϺ»³ú¿°
  • lethargic encephalitis
    ±â¸é³ú¿°
  • postinfectious encephalitis
    °¨¿°Èijú¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • encephalitis
    ³ú¿°
  • HIV
    (¢¡human immunodeficiency virus) »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute disseminated encephalitis
    ±Þ¼ºÆÄÁ¾³ú¿°
  • arthropod-borne encephalitis
    ÀýÁöµ¿¹°¸Å°³³ú¿°
  • demyelinating encephalitis
    ¸»ÀÌÁýÅ»¶ô³ú¿°
  • encephalitis
    ³ú¿°
  • epidemic encephalitis
    À¯Çà³ú¿°
  • forest spring encephalitis
    »ï¸²º½Ã¶³ú¿°
  • hemorrhagic encephalitis
    ÃâÇ÷³ú¿°
  • herpes simplex encephalitis
    ´Ü¼øÇ츣Æä½º³ú¿°
  • lethargic encephalitis
    Á¹À½Áõ³ú¿°, ±â¸é¼º³ú¿°
  • postinfectious encephalitis
    °¨¿°Èijú¿°
  • postvaccinal encephalitis
    ¿¹¹æÁ¢Á¾Èijú¿°
  • pyogenic encephalitis
    È­³ó³ú¿°
  • subacute sclerosing encephalitis
    ¾Æ±Þ¼º°æÈ­³ú¿°
  • suppurative encephalitis
    (¢¡pyogenic encephalitis) È­³ó³ú¿°
  • tick-borne encephalitis
    Áøµå±â¸Å°³³ú¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gag antigen in HIV infection
    HIV °¨¿°ÀÇ gag Ç׿ø
  • HIV => human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • HIV effect
    HIV È¿°ú<ÀÛ¿ë>
  • HIV infection
    HIV °¨¿°
  • HIV infection diagnosis
    HIV °¨¿°Áø´Ü
  • HIV testing
    HIV °Ë»ç
  • HIV-1
    Á¦1Çü »ç¶÷ ¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • HIV-2
    Á¦2Çü »ç¶÷ ¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • HIV=>human immunodeficiency virus
    ÀÎü ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
  • Human immunodeficiency virus = HIV
    »ç¶÷¸é¿ª°áÇ̼º ¹ÙÀÌ·¯½º
  • B encephalitis
    B ³ú¿° ¡ìÀϺ»³ú¿°¡í.
  • Dawsons encephalitis
    µµ¼Õ³ú¿°
  • Eastern equine encephalitis virus
    µ¿ºÎ¸»³ú¿°¹ÙÀÌ·¯½º
  • Eastern equine encephalitis virus
    µ¿ºÎ ¸» ³ú¿° ¹ÙÀÌ·¯½º
  • Murray valley encephalitis virus
    ¸Ó·¹À̰è°î ³ú¿°¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hiv(human immunodeficiency virus)
    ÀÎü¸é¿ª°áÇ̹ÙÀÌ·¯½º(ìÑô÷Øóæ¹ÌÀù¹¡­)
  • human immunodeficiency virus=HIV
    Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º
  • human immunodeficiency virus (HIV)
    »ç¶÷ ¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • human immunodeficiency virus (HIV) infection
    »ç¶÷ ¸é¿ª°áÇ̹ÙÀÌ·¯½º °¨¿°
  • human immunodeficiency virus = HIV
    Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
  • human immunodeficiency virus(HIV)
    »ç¶÷ ¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • acute disseminated encephalitis
    ±Þ¼º ÆÄÁ¾¼º ³ú¿°(¡­÷ëðúàõÒàæú).
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü³ú¿°(¡­Üæìýô÷Òàæú).
  • allergic encephalitis
    ¾Ë·¹¸£±â¼º ³ú¿° (¡­Òàæú).
  • allergic encephalitis
    ¾Ë·¹¸£±â[¼º] ³ú¿°
  • amyostatic encephalitis
    ±ÙºÒ¾ÈÁ¤¼º ³ú¿°(ÐÉÝÕäÌïÒàõÒàæú).
  • arboviral encephalitis
    ¾Æ¸£º¸¹ÙÀÌ·¯½º ³ú¿°
  • arboviral encephalitis
    ¾Æ¸£º¸¹ÙÀÌ·¯½º³ú¿°(¡­Òàæú)
  • arboviral encephalitis
    ¾Æº¸¹ÙÀÌ·¯½º³ú¿°
  • arboviral encephalitis
    ¾Æ¸£º¸¹ÙÀÌ·¯½º³ú¿°(¡­Òàæú).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arthropod-borne encephalitis
    ÀýÁöµ¿¹°¸Å°³³ú¿°
  • mosquito borne encephalitis
    ¸ð±â¸Å°³³ú¿°
  • tick-borne encephalitis
    Áøµå±â¸Å°³³ú¿°
  • Toxoplasma encephalitis
    Åå¼ÒÆ÷ÀÚÃæ³ú¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • HIV
    (å²) human immunodeficiency virus
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • encephalitis
    ³ú¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AIE acute inclusion-body encephalitis; acute infectious encephalitis; acute infective endocarditis
TE echo-time; expiratory time; tennis elbow; test ear; tetanus; tetracycline; threshold energy; thrombo...
VE vaginal examination; Venezuelan encephalitis; venous emptying; venous extension; ventilation; ventil...
HIV Human Immunodeficiency Virus
CD4 HIV helper cell count
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HIVE HIV encephalitis
HIV AN HIV associated nephropathy
HIV- HIV negative
HIV+ HIV positive
HIV Pr HIV protease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute HIV infection syndrome
    ±Þ¼º ÀÎü ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º Áúȯ °¨¿° ÁõÈıº
  • HIV
    Àΰ£ ¸é¿ª ¾ïÁ¦ ¹ÙÀÌ·¯½º
    Human Immunodeficiency VirusÀÇ Áظ». ÈÄõ¼º ¸é¿ª °áÇÌÁõ
  • HIV antibody
    HIV Ç×ü
  • HIV associated periodontal disease
    HIV¿Í °ü·ÃµÈ Ä¡ÁÖ Áúȯ
  • HIV disease
    ÀÎü ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º Áúȯ
  • acute disseminated encephalitis
    ±Þ¼º ÆÄÁ¾¼º ³ú¿°
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü ³ú¿°
  • arboviral encephalitis
    ¾Æ¸£º¸ ¹ÙÀÌ·¯½º ³ú¿°
  • chronic slow viral encephalitis
    ¸¸¼º Áö¿¬Çü ¹ÙÀÌ·¯½º¼º ³ú¿°
  • eastern equine encephalitis
    µ¿ºÎ¸¶ ³ú¿°, µ¿¾ç ¸¶Çü
  • encephalitis epidemica
    À¯Ç༺ ³ú¿°
  • encephalitis lethargica
    ±â¸é¼º ³ú¿°
    À¯Ç༺ ³ú¿°ÀÇ ÇÑ ÇüÀ¸·Î, ¿øÇüÀº von Economo¿¡ ÀÇÇØ¼­ º¸°íµÇ¾ú´Ù. ±ÇÅÂÀÇ Áõ°­, ¹«·Â »óÅÂ, Á¹À½À» Ư¡À¸·Î Çϰí, ±â¸é »óÅ·ΠÁøÇàµÈ´Ù. 1915¡­1926³â¿¡ ¼¼°è °¢Áö¿¡¼­ ¹ß»ýµÇ¾ú´Ù.
  • encephalitis periaxialis scleroticans
    °æÈ­¼º Ãà»è ÁÖÀ§ ³ú¿°
  • encephalitis syndrome
    ³ú¿° ÁõÈıº
  • Japanese encephalitis
    ÀϺ» ³ú¿°
    ÀϺ» ³ú¿° ¹ÙÀÌ·¯½º¿¡ ÀÇÇÑ À¯Ç༺ ³ú¿°. ¹ýÁ¤ Àü¿°º´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anti-HIV agents Agents used to treat aids and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with aids.
(12 Dec 1998)
receptors, HIV Cellular receptors that bind the human immunodeficiency virus that causes aids. Included are CD4 antigens, found on t4 lymphocytes, and monocytes/macrophages, which bind to the HIV envelope protein gp120.
(12 Dec 1998)
chronic symptomatic HIV infection This refers to an HIV infection that is characterised by signs and symptoms of HIV that are not life-threatening.
Examples include oral thrush, gingivitis, seborrheic dermatitis, molluscum contangiosum, fevers, fatigue, lymph node swelling, malaise and weight loss.
This stage can be a signal for the conversion from asymptomatic HIV disease to HIV disease (moe pronouced symptoms include joint pains). AIDS is diagnosed after HIV disease has started to manifest life-threatening oppotunistic infections (for example pneumocystis, cryptosporidium, toxoplasmosis, etc).
(27 Sep 1997)
middle stage HIV disease <disease> This refers to an HIV infection that is characterised by signs and symptoms of HIV that are not life-threatening.
Examples include oral thrush, gingivitis, seborrheic dermatitis, molluscum contangiosum, fevers, fatigue, lymph node swelling, malaise and weight loss. This stage can be a signal for the conversion from asymptomatic HIV disease to HIV disease (moe pronouced symptoms include joint pains). AIDS is diagnosed after HIV disease has started to manifest life-threatening oppotunistic infections (for example pneumocystis, cryptosporidium, toxoplasmosis, etc).
(27 Sep 1997)
primary HIV infection <infectious disease> The flu-like syndrome that oc immediately after a person contracts HIV. This mini infection precedes seroconversion and is characterised fever, sore throat, headache, skin rash and swollen glands.
(06 Mar 1998)
HIV <virology> A type of retrovirus (human immunodeficiency virus) that is responsible for the fatal illness acquired immunodeficiency syndrome. Two strains have been identified.
Type 1: the retrovirus recognised as the agent that induces AIDS.
Type 2: a virus closely related to HIV-1 that also leads to immune suppression. HIV-2 is not as virulent as HIV-1 and is epidemic only in West Africa.
Acronym: HIV
(11 Nov 1997)
HIV-1 The type species of lentivirus and widely recognised as the aetiologic agent of acquired immunodeficiency syndrome (aids). It is characterised by its cytopathic effect and affinity for the t4-lymphocyte.
(12 Dec 1998)
HIV-1 reverse transcriptase <enzyme> HIV-1 enzyme responsible for the synthesis of DNA from genomic RNA of the virus. It is encoded by the pol gene of HIV-1.
Registry number: EC 2.7.7.-
(12 Dec 1998)
HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian lentivirus siv and infects only t4-lymphocytes expressing the CD4 phenotypic marker.
(12 Dec 1998)
HIV-2 protease <enzyme> Processes hiv-1pr53(gag) and analogous junction peptides in vitro; less than 60% amino acid identity to hiv-1 protease
Registry number: EC 3.4.23.-
Synonym: hiv2 protease
(26 Jun 1999)
HIV-2 reverse transcriptase <enzyme> Responsible for synthesis of double-stranded DNA from the genomic RNA of the virus; has rnase h and DNA-dependent DNA polymerase activities; was indexed as reverse transcriptase (87-91)
Registry number: EC 2.7.7.-
(26 Jun 1999)
HIV antibodies Antibodies reactive with human immunodeficiency virus (HIV, previously called HTLV-III/lav) antigens of aids. This includes HIV-1 antibodies and HIV-2 antibodies.
(12 Dec 1998)
HIV antigens Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (lav) antigens.
(12 Dec 1998)
HIV core protein p24 A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by elisa and western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.
(12 Dec 1998)
HIV encephalopathy <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting.
Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • HIV
    human immunodeficiency virus;»ç¶÷ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º;AIDS ¹ÙÀÌ·¯½º
  • Japanese encephalitis
    ÀϺ»³ú¿°
  • encephalitis
    ³ú¿°
  • encephalitis lethargica
    (º´¸®)±â¸é¼º ³ú¿°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á